{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T10:58:24Z","timestamp":1769597904459,"version":"3.49.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T00:00:00Z","timestamp":1738108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001721","name":"University of Groningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology in Vitro"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.tiv.2025.106011","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T16:31:55Z","timestamp":1737563515000},"page":"106011","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Studying the intracellular bile acid concentration and toxicity in drug-induced cholestasis: Comprehensive LC-MS\/MS analysis with human liver slices"],"prefix":"10.1016","volume":"104","author":[{"given":"R.E.H.","family":"Karsten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Gier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.E.","family":"de Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.H.C.","family":"Huibers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.P.","family":"Permentier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Verpoorte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Olinga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tiv.2025.106011_bb0005","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1111\/apt.14678","article-title":"Review article: therapeutic bile acids and the risks for hepatotoxicity","volume":"47","author":"Ashby","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.tiv.2025.106011_bb0010","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/hep.510230534","article-title":"Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies","volume":"23","author":"Barone","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2025.106011_bb0015","doi-asserted-by":"crossref","first-page":"25187","DOI":"10.1038\/srep25187","article-title":"Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease","volume":"6","author":"Bell","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2025.106011_bb0020","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.cld.2013.07.015","article-title":"Drug-induced cholestasis","volume":"17","author":"Bhamidimarri","year":"2013","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.tiv.2025.106011_bb0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/toxsci\/kfz009","article-title":"Predictive value of cellular accumulation of hydrophobic bile acids as a marker of cholestatic drug potential","volume":"168","author":"Burban","year":"2019","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2025.106011_bb0030","doi-asserted-by":"crossref","first-page":"737","DOI":"10.21037\/atm-20-5110","article-title":"The role of bile acids in cholestatic liver injury","volume":"9","author":"Cai","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.tiv.2025.106011_bb0035","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2020.09.035","article-title":"Hepatic NFAT signaling regulates the expression of inflammatory cytokines in cholestasis","volume":"74","author":"Cai","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tiv.2025.106011_bb0040","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.taap.2013.10.032","article-title":"Hepatocyte-based in vitro model for assessment of drug-induced cholestasis","volume":"274","author":"Chatterjee","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106011_bb0045","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2003.11.006","article-title":"Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms","volume":"40","author":"Chiang","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tiv.2025.106011_bb0050","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/cphy.c120023","article-title":"Bile acid metabolism and signaling","volume":"3","author":"Chiang","year":"2013","journal-title":"Compr. Physiol."},{"key":"10.1016\/j.tiv.2025.106011_bb0055","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/01.ATV.0000178994.21828.a7","article-title":"The farnesoid X receptor","volume":"25","author":"Claudel","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.tiv.2025.106011_bb0060","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/hep.510290618","article-title":"Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid","volume":"29","author":"Combes","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2025.106011_bb0065","author":"Coreon"},{"key":"10.1016\/j.tiv.2025.106011_bb0070","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106011_bb0075","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1517\/17425255.3.6.879","article-title":"Precision-cut tissue slices as a tool to predict metabolism of novel drugs","volume":"3","author":"de Graaf","year":"2007","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.tiv.2025.106011_bb0080","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/nprot.2010.111","article-title":"Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies","volume":"5","author":"de Graaf","year":"2010","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tiv.2025.106011_bb0085","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/10408444.2019.1635081","article-title":"Current insights in the complexities underlying drug-induced cholestasis","volume":"49","author":"Deferm","year":"2019","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.tiv.2025.106011_bb0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0378-4274(92)90156-E","article-title":"Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: in vivo and in vitro studies","volume":"61","author":"Delzenne","year":"1992","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tiv.2025.106011_bb0095","doi-asserted-by":"crossref","first-page":"G1008","DOI":"10.1152\/ajpgi.00071.2004","article-title":"LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process","volume":"287","author":"Elferink","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.tiv.2025.106011_bb0100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0009-8981(96)06305-X","article-title":"Hepatic levels of bile acids in end-stage chronic cholestatic liver disease","volume":"251","author":"Fischer","year":"1996","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.tiv.2025.106011_bb0105","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1080\/10715760903176927","article-title":"Lipid and protein oxidation in hepatic homogenates and cell membranes exposed to bile acids","volume":"43","author":"Fuentes-Broto","year":"2009","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.tiv.2025.106011_bb0110","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1194\/jlr.D028803","article-title":"Targeted profiling of circulating and hepatic bile acids in human, mouse, and rat using a UPLC-MRM-MS-validated method","volume":"53","author":"Garc\u00eda-Ca\u00f1averas","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.tiv.2025.106011_bb0115","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00204-019-02437-2","article-title":"Mechanisms and in vitro models of drug-induced cholestasis","volume":"93","author":"Gijbels","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2025.106011_bb0120","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/j.gastro.2015.02.050","article-title":"Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system","volume":"148","author":"Goldberg","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2025.106011_bb0125","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/j.bbadis.2017.04.004","article-title":"Expression patterns of nuclear receptors in parenchymal and non-parenchymal mouse liver cells and their modulation in cholestasis","volume":"1863","author":"Gonzalez-Sanchez","year":"2017","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"key":"10.1016\/j.tiv.2025.106011_bb0130","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tiv.2025.106011_bb0135","doi-asserted-by":"crossref","first-page":"35434","DOI":"10.1038\/srep35434","article-title":"Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability","volume":"6","author":"Hendriks","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tiv.2025.106011_bb0140","article-title":"Current models for predicting drug-induced cholestasis: the role of hepatobiliary transport system","volume":"20","author":"Jazaeri","year":"2021","journal-title":"IJPR"},{"key":"10.1016\/j.tiv.2025.106011_bb0145","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-1-4939-9420-5_23","article-title":"Ex vivo model in cholestasis research","volume":"1981","author":"Karsten","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.tiv.2025.106011_bb0150","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-022-03321-2","article-title":"Mouse precision-cut liver slices as an ex vivo model to study drug-induced cholestasis","author":"Karsten","year":"2022","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2025.106011_bb0155","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/dmd.113.054304","article-title":"Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4","volume":"42","author":"K\u00f6ck","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106011_bb0160","first-page":"313","article-title":"Serum bile acids in cholestasis of pregnancy","volume":"50","author":"Laatikainen","year":"1977","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.tiv.2025.106011_bb0165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cld.2013.07.001","article-title":"Drug-induced acute liver failure","volume":"17","author":"Lee","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.tiv.2025.106011_bb0170","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1074\/jbc.M306422200","article-title":"The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion","volume":"279","author":"Lew","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2025.106011_bb0175","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/nu16050626","article-title":"Metabolic dysfunction-associated Steatotic liver disease in a dish: human precision-cut liver slices as a platform for drug screening and interventions","volume":"16","author":"Li","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.tiv.2025.106011_bb0180","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/toxsci\/kfq269","article-title":"Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development","volume":"118","author":"Morgan","year":"2010","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2025.106011_bb0185","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.jhep.2013.01.009","article-title":"Precision-cut liver slices: a tool to model the liver ex vivo","volume":"58","author":"Olinga","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.tiv.2025.106011_bb0190","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.vascn.2015.03.002","article-title":"Drug-induced cholestasis detection in cryopreserved rat hepatocytes in sandwich culture","volume":"73","author":"Oorts","year":"2015","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.tiv.2025.106011_bb0195","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1124\/jpet.121.000695","article-title":"Bosentan alters endo- and exogenous bile salt disposition in Sandwich-cultured human hepatocytes","volume":"379","author":"Oorts","year":"2021","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tiv.2025.106011_bb0200","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.toxlet.2018.06.1069","article-title":"Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent","volume":"295","author":"Parmentier","year":"2018","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tiv.2025.106011_bb0205","series-title":"Blumgart\u2019s Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set","first-page":"123","article-title":"Chapter 8 - bile secretion and pathophysiology of biliary tract obstruction","author":"Pitt","year":"2017"},{"key":"10.1016\/j.tiv.2025.106011_bb0210","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1007\/s00204-017-2002-1","article-title":"Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury","volume":"91","author":"Proctor","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2025.106011_bb0215","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1053\/jhep.2003.50256","article-title":"Regulation of rat organic anion transporters in bile salt-induced cholestatic hepatitis: effect of ursodeoxycholate","volume":"38","author":"Rost","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.tiv.2025.106011_bb0220","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/cts.12969","article-title":"Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation","volume":"14","author":"Rubiano","year":"2021","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.tiv.2025.106011_bb0225","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.ajpath.2016.06.003","article-title":"Pathogenesis of Kupffer cells in cholestatic liver injury","volume":"186","author":"Sato","year":"2016","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tiv.2025.106011_bb0230","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1016\/j.jchromb.2009.09.038","article-title":"Rapid quantification of bile acids and their conjugates in serum by liquid chromatography\u2013tandem mass spectrometry","volume":"877","author":"Scherer","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.tiv.2025.106011_bb0235","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/toxsci\/kfv155","article-title":"Cellular accumulation and toxic effects of bile acids in cyclosporine A-treated HepaRG hepatocytes","volume":"147","author":"Sharanek","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tiv.2025.106011_bb0240","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1124\/dmd.117.077420","article-title":"Progressive and preferential cellular accumulation of hydrophobic bile acids induced by cholestatic drugs is associated with inhibition of their amidation and sulfation","volume":"45","author":"Sharanek","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106011_bb0245","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1053\/j.gastro.2020.10.002","article-title":"High-fidelity drug-induced liver injury screen using human pluripotent stem cell\u2013derived organoids","volume":"160","author":"Shinozawa","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.tiv.2025.106011_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116560","article-title":"Yinchen decoction protects against cholic acid diet-induced cholestatic liver injury in mice through liver and ileal FXR signaling","volume":"313","author":"Song","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.tiv.2025.106011_bb0255","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.tiv.2015.10.008","article-title":"Viability, function and morphological integrity of precision-cut liver slices during prolonged incubation: effects of culture medium","volume":"30","author":"Starokozhko","year":"2015","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2025.106011_bb0260","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1007\/s00204-017-1960-7","article-title":"Rat precision-cut liver slices predict drug-induced cholestatic injury","volume":"91","author":"Starokozhko","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2025.106011_bb0265","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00204-016-1865-x","article-title":"Maintenance of drug metabolism and transport functions in human precision-cut liver slices during prolonged incubation for 5 days","volume":"91","author":"Starokozhko","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2025.106011_bb0270","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1124\/dmd.115.065425","article-title":"Prediction of the clinical risk of drug-induced cholestatic liver injury using an in vitro Sandwich cultured hepatocyte assay","volume":"43","author":"Susukida","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tiv.2025.106011_bb0275","first-page":"39","article-title":"Treatment of mouse liver slices with cholestatic hepatotoxicants results in down-regulation of Fxr and its target genes","volume":"6","author":"Szalowska","year":"2013","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.tiv.2025.106011_bb0280","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.bjp.0707235","article-title":"Hepatoprotective role of PXR activation and MRP3 in cholic acid-induced cholestasis","volume":"151","author":"Teng","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106011_bb0285","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1007\/s00204-016-1778-8","article-title":"Validation of precision-cut liver slices to study drug-induced cholestasis: a transcriptomics approach","volume":"91","author":"Vatakuti","year":"2017","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2025.106011_bb0290","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00204-018-2201-4","article-title":"In vitro prediction of drug-induced cholestatic liver injury: a challenge for the toxicologist","volume":"92","author":"Vinken","year":"2018","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.tiv.2025.106011_bb0295","doi-asserted-by":"crossref","first-page":"44475","DOI":"10.1074\/jbc.M305258200","article-title":"Resistance of SHP-null mice to bile acid-induced liver damage","volume":"278","author":"Wang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tiv.2025.106011_bb0300","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tiv.2016.05.012","article-title":"Human precision-cut liver slices as a model to test antifibrotic drugs in the early onset of liver fibrosis","volume":"35","author":"Westra","year":"2016","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.tiv.2025.106011_bb0305","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3727\/105221619X15614873062730","article-title":"Inflammation and cell death during cholestasis: the evolving role of bile acids","volume":"19","author":"Woolbright","year":"2019","journal-title":"Gene Expr."},{"key":"10.1016\/j.tiv.2025.106011_bb0310","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.taap.2015.01.015","article-title":"Bile acid-induced necrosis in primary human hepatocytes and in patients with obstructive cholestasis","volume":"283","author":"Woolbright","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tiv.2025.106011_bb0315","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1002\/jps.23584","article-title":"An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters","volume":"102","author":"Yang","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.tiv.2025.106011_bb0320","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drudis.2018.09.007","article-title":"Bile acid homeostasis paradigm and its connotation with cholestatic liver diseases","volume":"24","author":"Yang","year":"2019","journal-title":"Drug Discov. Today"}],"container-title":["Toxicology in Vitro"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233325000050?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0887233325000050?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T18:27:34Z","timestamp":1740508054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0887233325000050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":64,"alternative-id":["S0887233325000050"],"URL":"https:\/\/doi.org\/10.1016\/j.tiv.2025.106011","relation":{},"ISSN":["0887-2333"],"issn-type":[{"value":"0887-2333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Studying the intracellular bile acid concentration and toxicity in drug-induced cholestasis: Comprehensive LC-MS\/MS analysis with human liver slices","name":"articletitle","label":"Article Title"},{"value":"Toxicology in Vitro","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tiv.2025.106011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106011"}}